Connect your AI

Janux Therapeutics JANX Price / sales

Price / sales at other companies

Johnson & JohnsonJNJ

6.1×+1.6×

AmgenAMGN

5.1×+0.2×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

XencorXNCR

9.1×+3.2×

AbbVieABBV

6.1×-0.3×

Nektar TherapeuticsNKTR

37.1×+35.7×

Other financials

Income statement

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

Profitability

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Calculated from Janux Therapeutics’s reported figures.

market cap/total revenue=61.6×

Based on the most recent quarter.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Janux Therapeutics's price / sales?: Janux Therapeutics (JANX) reported price / sales of 61.6× in Q1 2026.
How has Janux Therapeutics's price / sales changed year-over-year?: Janux Therapeutics's price / sales decreased by 64.0% year-over-year, from 170.9× to 61.6×.
What is the long-term trend for Janux Therapeutics's price / sales?: Over 4 years (2021 to 2025), Janux Therapeutics's price / sales has grown at a -22.0% compound annual growth rate (CAGR), from 224.1× to 83×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.